Phillips-Medisize, a Molex company, said today that it has expanded the FDA-compliant manufacturing capacity of its Little Rock, Ark. plant.
The 380,000-square-foot facility is now fully compliant with the Current Good Manufacturing Practice (CGMP) regulations (21 CFR part 820) enforced by the FDA. The plant can now be used for Phillips-Medisize’s medical manufacturing services, including molding, stamping, plating and assembly, allowing for vertical integration of manufacturing, electronics and connected device solutions all in one site. The facility also has dedicated white space along with Class 8 cleanroom space for medical manufacturing.